ストックスクリーナーアプリを入手
2.09
0.48%
-0.01
アフターアワーズ：
2.09
前日終値:
$2.10
開ける：
$2.09
24時間の取引高:
209.75K
Relative Volume:
0.73
時価総額：
$36.21M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.97%
6か月 パフォーマンス:
-20.53%
1年 パフォーマンス:
-40.63%
1日の値動き範囲:
$2.08
$2.0945
1週間の範囲:
$2.08
$2.10
52週間の値動き範囲:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
MURA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.09 | 36.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-04 | 開始されました | Morgan Stanley | Overweight |
Mural Oncology Plc (MURA) 最新ニュース
Is Mural Oncology plc a candidate for recovery playRisk Management & Technical Pattern Based Buy Signals - newser.com
Is Mural Oncology plc stock ready for a breakoutWeekly Trend Recap & AI Driven Price Predictions - newser.com
Is Mural Oncology plc stock attractive for growth ETFsDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView
Exit strategy if you’re trapped in Mural Oncology plcPortfolio Update Summary & AI Driven Stock Price Forecasts - newser.com
Combining price and volume data for Mural Oncology plc2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Will Mural Oncology plc stock maintain dividend yieldMarket Risk Report & Smart Allocation Stock Tips - newser.com
Can trapped investors hope for a rebound in Mural Oncology plc2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-10-31 04:17:55 - newser.com
Why Mural Oncology plc stock is favored by pension funds2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
What candlestick patterns are forming on Mural Oncology plc2025 Volatility Report & Smart Allocation Stock Tips - newser.com
Mural Oncology plc (MURA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Mural Oncology plc (MURA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - TradingView
Why AXIL stock could see breakout soonTrade Risk Summary & Weekly Top Gainers Trade List - newser.com
Chart overlay techniques for tracking Mural Oncology plcTrade Volume Report & Daily Technical Stock Forecast Reports - newser.com
Citadel Group discloses 1.08% stake in Mural Oncology By Investing.com - Investing.com Australia
Can Mural Oncology plc stock resist sector downturnsMarket Weekly Review & Risk Controlled Swing Alerts - fcp.pa.gov.br
Citadel Group discloses 1.08% stake in Mural Oncology - Investing.com
Citadel Group discloses 0.99% stake in Mural Oncology By Investing.com - Investing.com Australia
Will Mural Oncology plc stock benefit from commodity pricesQuarterly Trade Report & Short-Term High Return Ideas - fcp.pa.gov.br
How Mural Oncology plc stock performs during Fed tightening cycles2025 Bull vs Bear & Growth-Oriented Investment Plans - newser.com
Why Mural Oncology plc stock could rally in 2025Analyst Upgrade & Accurate Entry/Exit Alerts - Fundação Cultural do Pará
Will Mural Oncology plc stock attract more institutional investorsPrice Action & Capital Efficiency Focused Ideas - fcp.pa.gov.br
Mural Oncology Plc Announces Acquisition by XOMA Royalty Corporation - MSN
Mural Oncology shareholders approve acquisition by XRA 5 Corp. - MSN
Aug Highlights: Why Mural Oncology plc stock could rally in 2025July 2025 Opening Moves & Safe Capital Investment Plans - fcp.pa.gov.br
Citadel Group discloses 0.99% stake in Mural Oncology - Investing.com
Mural Oncology Plc (MURA) 財務データ
Mural Oncology Plc (MURA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):